Categories Earnings

Earnings Summary Of J.B. Chemicals & Pharmaceuticals Limited For Q4 FY23

J.B. Chemicals & Pharmaceuticals Limited is a leading pharmaceutical company based in India. With a rich heritage of over four decades, the company has established itself as a trusted provider of high-quality pharmaceutical products and healthcare solutions. The company operates in various segments of the pharmaceutical industry, including formulations, active pharmaceutical ingredients (APIs), and branded generics. The company has a diverse product portfolio encompassing a wide range of therapeutic areas such as cardiovascular, respiratory, central nervous system, anti-infective, and gastrointestinal.

  • J.B. Chemicals & Pharmaceuticals Limited reported Total Income for Q4 FY23 of ₹766.90 Crore up from ₹626.67 Crore year on year, a growth of 22.4%.
  • Total Expenses for Q4 FY23 of ₹644.44 Crore up from ₹523.39 Crore year on year, a growth of 23.1%.
  • Consolidated Net Profit of ₹87.63 Crore, up 3% from ₹84.97 Crore in the same quarter of the previous year.
  • The Earnings per Share is ₹11.19, up from ₹10.96 in the same quarter of the previous year.

Most Popular

Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript

Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah

All you need to know about Antony Waste Handling Cell in one article

Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?

Demystifying the Leading Non-Ferrous Recycling Company of India

“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,

Top